Trump reportedly warns to ‘take the oil in Iran’ as Tehran targets water, power plants in Kuwait
The Middle East conflict has entered its fifth week, with attacks expanding across the region and raising risks to energy and infrastructure.
South Korea stocks fall 5%, leading regional declines as Middle East war enters fifth week
Asia-Pacific markets fell Monday as the Middle East war enters its fifth week.
Oil surges 3% as Iran war escalates with Yemen’s Houthis entering the Mideast conflict
Oil prices climbed on Monday after Yemen’s Houthis said they had fired missiles at Israel, opening a new front in the U.S.- and Israeli-led conflict with Iran.
Stock futures slide ahead of a holiday-shortened trading week: Live updates
The Dow Jones Industrial Average sank into correction territory on Friday, joining the Nasdaq, which entered a correction the day before.
France detains two more suspects over foiled Paris Bank of America attack
French police have arrested two more suspects over a foiled attack on Bank of America’s Paris offices.
Trump ban on investor homebuying may come at cost of a bigger real estate deal
President Trump’s plan to ban big investors from home ownership may not be the key to reviving the American Dream in affordable housing legislation.
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
Top Wall Street analysts like these dividend stocks for solid returns
These stocks that pay dividends consistently have the ability to generate long-term capital appreciation.
Which retailers win and lose from high gas prices? Deutsche Bank sorts it out
Companies indexed to higher-income customers are more likely to weather higher gas prices, the firm found.
Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.